Skip to content
Recall Observatory FDA recall evidence

Drug product

Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.

D-0929-2017

May 01, 2017

Class II

Product summary

Firm
Allergan Sales, LLC
Event
Event 77143
Status
Terminated
Classification
Class II
Quantity
648 units
Official record key
drug-enforcement:D-0929-2017

Official wording

Reason: Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.

Code information: Lot: 93802, EXP NOV 2019

Distribution pattern: Nationwide in the US

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications